Quality spec ific ations for the reliability performanc e c harac teristic s of laboratory tests, partic ularly prec ision and bias, are nec essary prerequisites for c reation and c ontrol of analytic al quality. Many
strategies have been promulgated for setting these. Rec ently, the available approac hes have been fixed into a hierarc hic al framework that has now been agreed by experts in the field to be the best c urrent approac h to a global strategy to set quality spec ific ations in laboratory medic ine. They should be inc orporated into quality planning strategies everywhere i rrespec tive of the settings in whic h laboratory medic ine is prac tised, inc luding POCT. Models higher in the hierarc hy are preferred to lower approac hes but lower approac hes are better than none and should be used if all that are available.
Introduction.
Every analytic al method, irrespec tive of where it is ac tually performed, c an be desc ribed fully in terms of its performanc e c harac teristic s. These are of two types, prac tic ability performanc e c harac teristic s and reliability performanc e c harac teristic s. The former inc lude skills required, speed of analysis, volume required, and type of sample required. The latter inc lude prec ision, bias, limit of detec tion, and measuring range. It is often suggested that, for point of c are testing [ POCT] , c onsiderations of speed of analysis -expressed as total turnaround time -surpass all others.
However, quality spec ific ations for the reliability performanc e c harac teristic s of laboratory tests, partic ularly prec ision and bias, are absolutely nec essary prerequisites for analytic al quality management. Moreover, suc h analytic al quality spec ific ations should be firmly based upon medic al requirements, useable in all laboratories irrespec tive of size, type or loc ation, generated using simple to understand models, and widely ac c epted as c ogent by professionals in the field.
Quality spec ific ations are required in many fac ets of the disc ipline, inc luding generating spec ific ations for new analytic al systems, assessing available literature to assist in method selec tion, evaluating submitted tenders, assessing data generated in method validation, and c reating appropriate internal quality c ontrol and external quality assessment sc hemes whic h guarantee the spec ified analytic al quality. A plethora of papers, reviews, and book c hapters dealing with the generation and applic ation of quality spec ific ations has been published over time [ 1 ] . However, there still seem to be real dilemmas in dec iding on appropriate quality spec ific ations, partic ularly for prec ision and bias. Although there are many very logic al reasons for this situation, a c ruc ial rec ent development was that a c onsensus was reac hed in 1 9 9 9 on global strategies to set quality spec ific ations in laboratory medic ine [ 2 ] . This c onsensus was based upon a hierarc hic al approac h published just prior to the c onsensus c onferenc e [ 3 ] .
The hierarc hy and its applic ation to the setting of analytic al quality spec ific ations for prec ision and bias are the subjec ts of this review.
Examples used are taken from those quantities often measured in POCT settings.
T he hierarchy of strategies to set quality specifications.
The hierarc hy shown in Table 1 has been agreed by experts in the field to be the best c urrent means to c lassify the available strategies. Assessment of the effect of analytical performance on specific clinical decisionmaking.
Clearly, the first c hoic e should logic ally be the strategy at the top of the hierarc hy. Thus, analytic al quality spec ific ations should be derived from analysis of the effec t of analytic al quality on medic al However, a signific ant problem with this approac h is that only very Thus, if pre-analytic al sourc es of variation are minimised, then, to assess whether c hange has oc c urred, it must exc eed the inherent variation due to biologic al and analytic al variation whic h is defined as the referenc e c hange value. The referenc e c hange value
[ RCV] c an be c alc ulated as -
where Z is the number of standard deviates appropriate to the probability selec ted [ for example, 1 .9 6 for P < 0 .0 5 and 2 .5 6 for P < 0 .0 1 ] .
It is simple to demonstrate the effec t of prec ision on medic al dec ision-making. Taking c holesterol [ CV I ~ 6 %] as an example, the c hange required for signific anc e [ at P < 0 .0 5 ] inc reases with prec ision as shown in Table 1 .
For prec ision, the widely ac c epted quality spec ific ation is that the analytic al variation [ CV A ] should be less than one-half the average within-subjec t biologic al variation [ 7 ] . Harris showed that, if CV A < 0 .5 0 CV I , then the amount of variability added was about 1 0 % [ in reality, 1 1 .8 %] whic h was stated to be "reasonable" From Hyltoft Petersen, et al. Clin Chim A cta 1997; 260:200. between-subjec t biologic al variation, have been proposed as shown in Figure 5 [ 9 ] .
These well established approac hes have advantages in that data on c omponents of biologic al variation are available for more than 2 0 0 quantities. A rec ent c ompilation in the easily available literature makes the data easy to obtain [ 1 1 ] , and the data seem independent of study loc ation, number of subjec ts, length of study, Published data on the state of the art.
Quality spec ific ations c ould be generated through referenc e to the performanc e ac hieved by groups of laboratories partic ipating in EQA and PT sc hemes. This has the advantage that many data are often available. However, for a number of obvious reasons, true analytic al performanc e may not be ac c urately mirrored by this apparent state of the art.
Measures of the quality of analytic al performanc e c ould be obtained be c omparison with attainment doc umented in published works on similar or other assay methods for the quantity for whic h quality spec ific ations were required. This has some merit in that many data are often available, but has the real diffic ulty that published method performanc e may be the best possible rather than that ac hieved in prac tic e. Again, performanc e ac hieved analytic ally may bear no relationship to ac tual medic al needs. With regard to POCT, a problem is that many evaluations of tec hnology 
Conclusions.
A hierarc hy of approac hes to set analytic al quality spec ific ations has been c reated and approved by expert professionals. The hierarc hy should be applied in prac tic e. These simple to understand models are appropriate for all settings in whic h laboratory medic ine is prac tised, inc luding POCT, and they should be inc orporated into quality planning strategies everywhere. As we have stated previously in a review on quality spec ific ations for analyses done in alternate sites inc luding POCT [ 2 1 ] , there is no reason why different standards are warranted, and we have tabled general numeric al analytic al quality spec ific ations based on biologic al variation for test c ommonly performed as POCT. Clearly, models higher in the hierarc hy are preferred to lower approac hes but lower approac hes are better than none and should be used if all that are available. New useful models may be developed in the future and these should be inc orporated into the hierarc hic al sc heme when widely approved by professionals in laboratory medic ine.
Figure 5. Percentage of results outside reference limits due to analytical bias [expressed as a ratio of analytical to group (withinplus between-subject) biological variation]
showing three possible quality specifications based on biological variation. From Fraser CG et al. A nn Clin Biochem 1997; 34:8-12. 
